Agilent Technologies EBITDA Margin 2010-2025 | A
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Agilent Technologies (A) over the last 10 years. The current EBITDA margin for Agilent Technologies as of April 30, 2025 is .
| Agilent Technologies EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2025-04-30 |
$6.63B |
$1.69B |
25.56% |
| 2025-01-31 |
$6.53B |
$1.75B |
26.74% |
| 2024-10-31 |
$6.51B |
$1.75B |
26.80% |
| 2024-07-31 |
$6.50B |
$1.74B |
26.75% |
| 2024-04-30 |
$6.59B |
$1.55B |
23.46% |
| 2024-01-31 |
$6.74B |
$1.57B |
23.37% |
| 2023-10-31 |
$6.83B |
$1.62B |
23.72% |
| 2023-07-31 |
$6.99B |
$1.70B |
24.24% |
| 2023-04-30 |
$7.04B |
$1.98B |
28.15% |
| 2023-01-31 |
$6.93B |
$1.97B |
28.43% |
| 2022-10-31 |
$6.85B |
$1.94B |
28.26% |
| 2022-07-31 |
$6.66B |
$1.87B |
28.08% |
| 2022-04-30 |
$6.53B |
$1.80B |
27.56% |
| 2022-01-31 |
$6.45B |
$1.72B |
26.72% |
| 2021-10-31 |
$6.32B |
$1.67B |
26.40% |
| 2021-07-31 |
$6.14B |
$1.56B |
25.46% |
| 2021-04-30 |
$5.82B |
$1.45B |
24.94% |
| 2021-01-31 |
$5.53B |
$1.26B |
22.86% |
| 2020-10-31 |
$5.34B |
$1.15B |
21.61% |
| 2020-07-31 |
$5.22B |
$1.11B |
21.16% |
| 2020-04-30 |
$5.24B |
$1.08B |
20.59% |
| 2020-01-31 |
$5.24B |
$1.17B |
22.33% |
| 2019-10-31 |
$5.16B |
$1.18B |
22.84% |
| 2019-07-31 |
$5.09B |
$1.15B |
22.65% |
| 2019-04-30 |
$5.02B |
$1.15B |
22.85% |
| 2019-01-31 |
$4.99B |
$1.14B |
22.82% |
| 2018-10-31 |
$4.91B |
$1.11B |
22.67% |
| 2018-07-31 |
$4.81B |
$1.07B |
22.15% |
| 2018-04-30 |
$4.72B |
$1.04B |
22.10% |
| 2018-01-31 |
$4.62B |
$1.04B |
22.49% |
| 2017-10-31 |
$4.47B |
$1.02B |
22.79% |
| 2017-07-31 |
$4.39B |
$1.01B |
22.92% |
| 2017-04-30 |
$4.32B |
$0.96B |
22.22% |
| 2017-01-31 |
$4.24B |
$0.90B |
21.24% |
| 2016-10-31 |
$4.20B |
$0.86B |
20.49% |
| 2016-07-31 |
$4.13B |
$0.84B |
20.31% |
| 2016-04-30 |
$4.10B |
$0.84B |
20.46% |
| 2016-01-31 |
$4.04B |
$0.81B |
20.12% |
| 2015-10-31 |
$4.04B |
$0.78B |
19.19% |
| 2015-07-31 |
$4.81B |
$0.81B |
16.89% |
| 2015-04-30 |
$4.80B |
$0.83B |
17.22% |
| 2015-01-31 |
$4.83B |
$0.85B |
17.56% |
| 2014-10-31 |
$4.81B |
$0.89B |
18.40% |
| 2014-07-31 |
$4.72B |
$1.01B |
21.43% |
| 2014-04-30 |
$5.37B |
$1.12B |
20.83% |
| 2014-01-31 |
$6.11B |
$1.23B |
20.16% |
| 2013-10-31 |
$6.78B |
$1.32B |
19.51% |
| 2013-07-31 |
$6.83B |
$1.32B |
19.25% |
| 2013-04-30 |
$6.90B |
$1.34B |
19.44% |
| 2013-01-31 |
$6.90B |
$1.40B |
20.25% |
| 2012-10-31 |
$6.86B |
$1.42B |
20.71% |
| 2012-07-31 |
$6.82B |
$1.42B |
20.88% |
| 2012-04-30 |
$6.79B |
$1.41B |
20.83% |
| 2012-01-31 |
$6.73B |
$1.38B |
20.55% |
| 2011-10-31 |
$6.62B |
$1.32B |
20.02% |
| 2011-07-31 |
$6.46B |
$1.22B |
18.85% |
| 2011-04-30 |
$6.16B |
$1.05B |
17.04% |
| 2011-01-31 |
$5.75B |
$0.91B |
15.81% |
| 2010-10-31 |
$5.44B |
$0.77B |
14.11% |
| 2010-07-31 |
$5.04B |
$0.61B |
12.10% |
| 2010-04-30 |
$4.71B |
$0.47B |
10.07% |
| 2010-01-31 |
$4.53B |
$0.28B |
6.12% |
| 2009-10-31 |
$4.48B |
$0.21B |
4.66% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$34.119B |
$6.510B |
|
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
|
